Back to Results
First PageMeta Content
Australian Securities Exchange / Economy of New South Wales / Proxy voting / Business / Ordinary resolution / Economy of Australia / Corporations law / Business law / Law


Microsoft Word[removed]GENERAL MEETING RESULTS.docx
Add to Reading List

Document Date: 2014-04-13 21:12:40

Open Document

File Size: 152,10 KB

Share Result on Facebook

City

Sydney / /

Company

Benitec Biopharma Limited / /

Country

United States / Australia / /

Currency

USD / /

/

Event

Funding / Company Listing Change / /

IndustryTerm

licensed ddRNAi technology / biopharmaceutical / biotechnology / gene‐silencing technology / /

MedicalCondition

oculopharyngeal muscular dystrophy / resistant lung cancer / cancer / retinitis pigmentosa / macular degeneration / Huntington’s disease / Hepatitis C / Hepatitis B / pain / HIV/AIDS / /

Person

Peter French / Carl Stubbings / Jane Lowe / /

/

Position

CEO / Chief Business Officer / General / /

Technology

licensed ddRNAi technology / gene‐silencing technology / biotechnology / /

URL

www.benitec.com / /

SocialTag